Table 1 Demographic, clinical and laboratory features of the study patients
Characteristic | Value |
|---|---|
Number of patients | 232 |
Male/female | 178 (76.7 %)/54 (23.3 %) |
Age (years) | 46.1 ± 10.5 (45; 21–69) |
HBeAg positivity | 142 (61.2 %) |
HBV DNA (lg copies/mL) | 4.1 ± 2.5 |
TBil (mg/dL) | 22.2 ± 9.2 |
Cr (mg/dL) | 0.93 ± 0.74 |
PTA (%) | 27.1 ± 16.8 |
INR | 4.2 ± 2.2 |
Albumin (g/L) | 32.1 ± 5.0 |
Preexisting cirrhosis | 112 (48.3 %) |
Ascites | 194 (83.6 %) |
SBP | 152 (65.5 %) |
HE | 64 (27.6 %) |
HRS | 37 (16.0 %) |
MELD | 29.0 ± 5.4 |
LRM | −0.6 ± 1.4 |
ALSS treatment | 104 (44.8 %) |
3-month survival | 121(52.2 %) |